FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200304840> ?p ?o ?g. }

• W4200304840 endingPage "104452" @default.
• W4200304840 startingPage "104452" @default.
• W4200304840 abstract "Canine chronic enteropathy (CCE) is a collective term used to describe a group of idiopathic enteropathies of dogs that result in a variety of clinical manifestations of intestinal dysfunction. Clinical stratification into food-responsive enteropathy (FRE) or non-food responsive chronic inflammatory enteropathy (CIE), is made retrospectively based on response to treatments. Faecal extracts from those with a FRE (n = 5) and those with non-food responsive chronic inflammatory enteropathies (CIE) (n = 6) were compared to a healthy control group (n = 14) by applying TMT-based quantitative proteomic approach. Many of the proteins with significant differential abundance between groups were pancreatic or intestinal enzymes with pancreatitis-associated protein (identified as REG3α) and pancreatic M14 metallocarboxypeptidase proteins carboxypeptidase A1 and B identified as being of significantly increased abundance in the CCE group. The reactome analysis revealed the recycling of bile acids and salts and their metabolism to be present in the FRE group, suggesting a possible dysbiotic aetiology. Several acute phase proteins were significantly more abundant in the CCE group with the significant increase in haptoglobin in the CIE group especially notable. Further research of these proteins is needed to fully assess their clinical utility as faecal biomarkers for differentiating CCE cases. SIGNIFICANCE: The identification and characterisation of biomarkers that differentiate FRE from other forms of CIE would prove invaluable in streamlining clinical decision-making and would avoid costly and invasive investigations and delays in implementing effective treatment. Many of the proteins described here, as canine faecal proteins for the first time, have been highlighted in previous human and murine inflammatory bowl disease (IBD) studies initiating a new chapter in canine faecal biomarker research, where early and non-invasive biomarkers for early clinical stratification of CCE cases are needed. Pancreatitis-associated protein, pancreatic M14 metallocarboxypeptidase along with carboxypeptidase A1 and B are identified as being of significantly increased abundance in the CCE groups. Several acute phase proteins, were significantly more abundant in the CCE group notably haptoglobin in dogs with inflammatory enteropathy. The recognition of altered bile acid metabolism in the reactome analysis in the FRE group is significant in CCE which is a complex condition incorporating of immunological, dysbiotic and faecal bile acid dysmetabolism. Both proteomics and immunoassays will enable the characterisation of faecal APPs as well as other inflammatory and immune mediators, and the utilisation of assays, validated for use in analysis of faeces of veterinary species will enable clinical utilisation of faecal matrix to be fully realised." @default.
• W4200304840 created "2021-12-31" @default.
• W4200304840 creator A5017278208 @default.
• W4200304840 creator A5018208670 @default.
• W4200304840 creator A5019287310 @default.
• W4200304840 creator A5038933301 @default.
• W4200304840 creator A5047700485 @default.
• W4200304840 creator A5053319660 @default.
• W4200304840 creator A5053845451 @default.
• W4200304840 creator A5058842387 @default.
• W4200304840 creator A5059020994 @default.
• W4200304840 creator A5090427791 @default.
• W4200304840 date "2022-03-01" @default.
• W4200304840 modified "2023-09-23" @default.
• W4200304840 title "Faecal proteomics in the identification of biomarkers to differentiate canine chronic enteropathies" @default.
• W4200304840 cites W1495820093 @default.
• W4200304840 cites W177681128 @default.
• W4200304840 cites W1972090336 @default.
• W4200304840 cites W1990208114 @default.
• W4200304840 cites W2002483612 @default.
• W4200304840 cites W2005299390 @default.
• W4200304840 cites W2006086447 @default.
• W4200304840 cites W2017739484 @default.
• W4200304840 cites W2029875484 @default.
• W4200304840 cites W2044700386 @default.
• W4200304840 cites W2044831051 @default.
• W4200304840 cites W2061325485 @default.
• W4200304840 cites W2063079093 @default.
• W4200304840 cites W2069682711 @default.
• W4200304840 cites W2071399992 @default.
• W4200304840 cites W2114633742 @default.
• W4200304840 cites W2123032013 @default.
• W4200304840 cites W2126743932 @default.
• W4200304840 cites W2129449792 @default.
• W4200304840 cites W2131691531 @default.
• W4200304840 cites W2136050048 @default.
• W4200304840 cites W2141440140 @default.
• W4200304840 cites W2157824315 @default.
• W4200304840 cites W2179315885 @default.
• W4200304840 cites W2293579221 @default.
• W4200304840 cites W2538301580 @default.
• W4200304840 cites W2783196966 @default.
• W4200304840 cites W2785546124 @default.
• W4200304840 cites W2790895425 @default.
• W4200304840 cites W2797736339 @default.
• W4200304840 cites W2809071119 @default.
• W4200304840 cites W2899760200 @default.
• W4200304840 cites W2907836656 @default.
• W4200304840 cites W2946819319 @default.
• W4200304840 cites W2949769249 @default.
• W4200304840 cites W3010127435 @default.
• W4200304840 cites W3161039645 @default.
• W4200304840 doi "https://doi.org/10.1016/j.jprot.2021.104452" @default.
• W4200304840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34958965" @default.
• W4200304840 hasPublicationYear "2022" @default.
• W4200304840 type Work @default.
• W4200304840 citedByCount "7" @default.
• W4200304840 countsByYear W42003048402022 @default.
• W4200304840 countsByYear W42003048402023 @default.
• W4200304840 crossrefType "journal-article" @default.
• W4200304840 hasAuthorship W4200304840A5017278208 @default.
• W4200304840 hasAuthorship W4200304840A5018208670 @default.
• W4200304840 hasAuthorship W4200304840A5019287310 @default.
• W4200304840 hasAuthorship W4200304840A5038933301 @default.
• W4200304840 hasAuthorship W4200304840A5047700485 @default.
• W4200304840 hasAuthorship W4200304840A5053319660 @default.
• W4200304840 hasAuthorship W4200304840A5053845451 @default.
• W4200304840 hasAuthorship W4200304840A5058842387 @default.
• W4200304840 hasAuthorship W4200304840A5059020994 @default.
• W4200304840 hasAuthorship W4200304840A5090427791 @default.
• W4200304840 hasBestOaLocation W42003048402 @default.
• W4200304840 hasConcept C104317684 @default.
• W4200304840 hasConcept C126322002 @default.
• W4200304840 hasConcept C137627325 @default.
• W4200304840 hasConcept C203014093 @default.
• W4200304840 hasConcept C206396517 @default.
• W4200304840 hasConcept C2775967933 @default.
• W4200304840 hasConcept C2778426112 @default.
• W4200304840 hasConcept C2779134260 @default.
• W4200304840 hasConcept C2780439177 @default.
• W4200304840 hasConcept C46111723 @default.
• W4200304840 hasConcept C55493867 @default.
• W4200304840 hasConcept C63363279 @default.
• W4200304840 hasConcept C71924100 @default.
• W4200304840 hasConcept C86803240 @default.
• W4200304840 hasConcept C90924648 @default.
• W4200304840 hasConceptScore W4200304840C104317684 @default.
• W4200304840 hasConceptScore W4200304840C126322002 @default.
• W4200304840 hasConceptScore W4200304840C137627325 @default.
• W4200304840 hasConceptScore W4200304840C203014093 @default.
• W4200304840 hasConceptScore W4200304840C206396517 @default.
• W4200304840 hasConceptScore W4200304840C2775967933 @default.
• W4200304840 hasConceptScore W4200304840C2778426112 @default.
• W4200304840 hasConceptScore W4200304840C2779134260 @default.
• W4200304840 hasConceptScore W4200304840C2780439177 @default.
• W4200304840 hasConceptScore W4200304840C46111723 @default.
• W4200304840 hasConceptScore W4200304840C55493867 @default.
• W4200304840 hasConceptScore W4200304840C63363279 @default.

• next